InspireMD, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
InspireMD, Inc. (NSPR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 3.64% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-03-18
- InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-03-31 was 3.68%, a 93.68% increase year-over-year.
- InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2022-03-31 was 1.90%.
- InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 3.64%, a 18.02% decline from fiscal 2024.
- InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.44%, a 6.13% decline from fiscal 2023.
- InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 4.73%, a 64.24% increase from fiscal 2022.
- InspireMD, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 2.88%, a 105.71% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2025-12-31 | 3.64% 10-K · filed 2026-03-18 | |||
| 2024-12-31 | 4.44% 10-K · filed 2026-03-18 | |||
| 2023-12-31 | 4.73% 10-K · filed 2025-03-12 | |||
| 2023-03-31 | 3.68% 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | 2.88% 10-K · filed 2024-03-05 | |||
| 2022-09-30 | 2.88% 10-Q · filed 2022-11-07 | |||
| 2022-06-30 | 2.88% 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | 1.90% 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | 1.40% 10-K · filed 2023-03-30 | |||
| 2020-12-31 | 0.42% 10-K · filed 2022-03-07 | |||
| 2016-06-30 | 1.25% 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |